Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 7, Pages -
Publisher
American Society for Microbiology
Online
2022-06-14
DOI
10.1128/aac.00563-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
- (2022) Stefan Hagel et al. INTENSIVE CARE MEDICINE
- Another trial for the TARGET trial
- (2022) Mohammad H. Alshaer et al. INTENSIVE CARE MEDICINE
- Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics
- (2021) Mohammad H. Alshaer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ventilator-associated pneumonia in adults: a narrative review
- (2020) Laurent Papazian et al. INTENSIVE CARE MEDICINE
- Population pharmacokinetics and target attainment of cefepime in critically ill patients and guidance for initial dosing
- (2020) Mohammad H. Al-Shaer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials
- (2019) Emmanuel Weiss et al. CLINICAL INFECTIOUS DISEASES
- Individualising Therapy to Minimize Bacterial Multidrug Resistance
- (2018) A. J. Heffernan et al. DRUGS
- Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by gram-negative bacilli: a systematic review
- (2018) Aaron J Heffernan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria
- (2017) Vincent H. Tam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients
- (2016) Sumith K. Mathew et al. THERAPEUTIC DRUG MONITORING
- Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
- (2015) Angela Huttner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
- (2014) T. W. Felton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Are Blood Concentrations Enough for Establishing Pharmacokinetic/Pharmacodynamic Relationships?
- (2014) W. A. Craig CLINICAL INFECTIOUS DISEASES
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- (2014) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
- (2013) Wilhelmina G Melsen et al. LANCET INFECTIOUS DISEASES
- Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort
- (2012) Marin H. Kollef et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
- (2012) Michael N. Neely et al. THERAPEUTIC DRUG MONITORING
- Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator‐Associated Pneumonia and Hospital‐Acquired Pneumonia
- (2010) John G. Muscedere et al. CLINICAL INFECTIOUS DISEASES
- Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
- (2010) Ronald N. Jones CLINICAL INFECTIOUS DISEASES
- Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States
- (2010) Pornpan Koomanachai et al. CLINICAL THERAPEUTICS
- Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa
- (2009) J. L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now